Free Trial

CohBar (CWBR) Competitors

CohBar logo
$0.50 0.00 (0.00%)
(As of 11/21/2024 ET)

CWBR vs. NOVN, PPBT, HOTH, BMRA, UPXI, AEZS, ORGS, HURA, ONVO, and ALZN

Should you be buying CohBar stock or one of its competitors? The main competitors of CohBar include Novan (NOVN), Purple Biotech (PPBT), Hoth Therapeutics (HOTH), Biomerica (BMRA), Upexi (UPXI), Aeterna Zentaris (AEZS), Orgenesis (ORGS), TuHURA Biosciences (HURA), Organovo (ONVO), and Alzamend Neuro (ALZN).

CohBar vs.

Novan (NASDAQ:NOVN) and CohBar (NASDAQ:CWBR) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, valuation, community ranking, profitability, analyst recommendations, risk, dividends and earnings.

14.5% of Novan shares are held by institutional investors. Comparatively, 2.5% of CohBar shares are held by institutional investors. 1.3% of Novan shares are held by company insiders. Comparatively, 6.5% of CohBar shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

CohBar has a net margin of 0.00% compared to Novan's net margin of -128.61%. CohBar's return on equity of 0.00% beat Novan's return on equity.

Company Net Margins Return on Equity Return on Assets
Novan-128.61% -700.28% -39.58%
CohBar N/A N/A N/A

Novan received 221 more outperform votes than CohBar when rated by MarketBeat users. However, 72.00% of users gave CohBar an outperform vote while only 53.11% of users gave Novan an outperform vote.

CompanyUnderperformOutperform
NovanOutperform Votes
239
53.11%
Underperform Votes
211
46.89%
CohBarOutperform Votes
18
72.00%
Underperform Votes
7
28.00%

Novan has a beta of -0.06, meaning that its stock price is 106% less volatile than the S&P 500. Comparatively, CohBar has a beta of 1.37, meaning that its stock price is 37% more volatile than the S&P 500.

CohBar has lower revenue, but higher earnings than Novan.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Novan$24.71M0.00-$31.31M-$1.32N/A
CohBarN/AN/A-$12.18MN/AN/A

In the previous week, Novan's average media sentiment score of 0.00 equaled CohBar'saverage media sentiment score.

Company Overall Sentiment
Novan Neutral
CohBar Neutral

Summary

CohBar beats Novan on 7 of the 10 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CWBR vs. The Competition

MetricCohBarPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$1.46M$6.58B$5.10B$8.88B
Dividend YieldN/A8.11%5.02%4.07%
P/E RatioN/A10.30131.9117.40
Price / SalesN/A362.861,212.5785.49
Price / CashN/A52.5939.3836.27
Price / Book0.0910.176.906.36
Net Income-$12.18M$153.60M$118.88M$225.88M
7 Day Performance2.04%2.65%1.00%1.83%
1 Month Performance2.04%-9.38%-4.20%1.65%
1 Year Performance-44.44%28.29%30.91%26.68%

CohBar Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CWBR
CohBar
N/A$0.50
flat
N/A-44.2%$1.46MN/A0.0010
NOVN
Novan
N/AN/AN/AN/A$2.64M$24.71M-0.0790Gap Up
High Trading Volume
PPBT
Purple Biotech
1.8041 of 5 stars
$2.54
+2.8%
$33.00
+1,199.2%
N/A$3.38MN/A-0.2920
HOTH
Hoth Therapeutics
2.4675 of 5 stars
$0.84
+1.2%
$3.50
+319.2%
-21.2%$5.76MN/A-0.634
BMRA
Biomerica
0.2098 of 5 stars
$0.34
+3.1%
N/A-60.3%$5.46M$5.51M-0.9160News Coverage
Gap Down
UPXI
Upexi
1.4374 of 5 stars
$5.14
+16.8%
$25.00
+386.4%
-73.2%$5.35M$80.68M0.00130
AEZS
Aeterna Zentaris
N/A$2.98
-0.7%
N/A-56.2%$5.35M$2.37M-0.2020
ORGS
Orgenesis
1.7492 of 5 stars
$1.10
+0.9%
N/AN/A$5.28M$530,000.000.00150Gap Down
HURA
TuHURA Biosciences
0.9667 of 5 stars
$3.37
+2.4%
$15.00
+345.1%
N/A$5.24MN/A0.00N/ANegative News
Gap Up
ONVO
Organovo
0.682 of 5 stars
$0.34
-2.9%
N/A-73.0%$5.23M$110,000.00-0.3320Analyst Forecast
ALZN
Alzamend Neuro
1.6165 of 5 stars
$1.30
-0.8%
$35.00
+2,592.3%
-88.1%$5.06MN/A0.004

Related Companies and Tools


This page (NASDAQ:CWBR) was last updated on 11/22/2024 by MarketBeat.com Staff
From Our Partners